[{"address1": "Bellevue Centre", "address2": "Suite 300 235 -15th Street", "city": "West Vancouver", "state": "BC", "zip": "V7T 2X1", "country": "Canada", "phone": "604 921 1810", "fax": "604 921 1898", "website": "https://briacell.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Dr. William V. Williams M.D.", "age": 68, "title": "CEO, President & Director", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": 785305, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gadi  Levin B.Com., C.A., CPA, M.B.A.", "age": 50, "title": "CFO & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 304465, "exercisedValue": 0, "unexercisedValue": 211106}, {"maxAge": 1, "name": "Dr. Miguel A. Lopez-Lago Ph.D.", "age": 54, "title": "Chief Scientific Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 298897, "exercisedValue": 0, "unexercisedValue": 2598}, {"maxAge": 1, "name": "Dr. Giuseppe  Del Priore M.D., M.P.H., MPH", "age": 61, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 492505, "exercisedValue": 0, "unexercisedValue": 2598}, {"maxAge": 1, "name": "Dr. Charles Louis Wiseman FACP, M.D.", "age": 77, "title": "Founder, Principal Research Advisor & Member of Scientific Advisory Board", "yearBorn": 1946, "fiscalYear": 2023, "totalPay": 241138, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.36, "open": 1.37, "dayLow": 1.305, "dayHigh": 1.42, "regularMarketPreviousClose": 1.36, "regularMarketOpen": 1.37, "regularMarketDayLow": 1.305, "regularMarketDayHigh": 1.42, "beta": 1.84, "forwardPE": -1.42, "volume": 61934, "regularMarketVolume": 61934, "averageVolume": 122760, "averageVolume10days": 79290, "averageDailyVolume10Day": 79290, "bid": 1.38, "ask": 1.43, "bidSize": 100, "askSize": 100, "marketCap": 25964274, "fiftyTwoWeekLow": 1.27, "fiftyTwoWeekHigh": 7.59, "fiftyDayAverage": 1.9384, "twoHundredDayAverage": 3.8513, "currency": "USD", "enterpriseValue": 16205105, "floatShares": 11399765, "sharesOutstanding": 18284700, "sharesShort": 645689, "sharesShortPriorMonth": 685017, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0404, "heldPercentInsiders": 0.15557, "heldPercentInstitutions": 0.1204, "shortRatio": 15.21, "shortPercentOfFloat": 0.0461, "impliedSharesOutstanding": 18841200, "bookValue": -0.505, "lastFiscalYearEnd": 1690761600, "nextFiscalYearEnd": 1722384000, "mostRecentQuarter": 1706659200, "netIncomeToCommon": -12607151, "trailingEps": -0.79, "forwardEps": -1.0, "lastSplitFactor": "1:300", "lastSplitDate": 1577923200, "enterpriseToEbitda": -0.511, "52WeekChange": -0.7530435, "SandP52WeekChange": 0.23763025, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BCTX", "underlyingSymbol": "BCTX", "shortName": "BriaCell Therapeutics Corp.", "longName": "BriaCell Therapeutics Corp.", "firstTradeDateEpochUtc": 1331731800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "4582bc39-2d8c-30ab-8663-2245a7a6ffd9", "messageBoardId": "finmb_262266102", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.42, "targetHighPrice": 18.0, "targetLowPrice": 18.0, "targetMeanPrice": 18.0, "targetMedianPrice": 18.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 6244528, "totalCashPerShare": 0.391, "ebitda": -31699992, "quickRatio": 1.599, "currentRatio": 2.992, "returnOnAssets": -0.85454005, "freeCashflow": -19762984, "operatingCashflow": -31257302, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-15"}]